Drug Discovery · Charlottesville, VA · Founded 2015 · Privately Held (backing)
Developer of a male contraceptive product intended to provide non-surgical and reversible birth control procedures. Contraline is based in Charlottesville, VA and was founded in 2015. Its last reported valuation was $60 million in Feb 2025. It has raised $41.7 million across 3 recorded rounds; the latest was a $55.8 million later-stage round in May 2026.
Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$41.7M
Last round
Later Stage VC
May 2026
Cap table — not yet on record
Contraline's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Contraline with a free account
·The complete investor list: 52 names
·Watch Contraline: the Monday email on marks, rounds and moves